International Biotechnology Trust’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-46,000
| Closed | -$464K | – | 66 |
|
2022
Q4 | $464K | Sell |
46,000
-75,000
| -62% | -$756K | 0.14% | 59 |
|
2022
Q3 | $2.71M | Buy |
121,000
+117,083
| +2,989% | +$2.62M | 0.87% | 35 |
|
2022
Q2 | $158K | Sell |
3,917
-24,083
| -86% | -$971K | 1.65% | 20 |
|
2022
Q1 | $5.64M | Hold |
28,000
| – | – | 1.27% | 26 |
|
2021
Q4 | $1.64M | Hold |
28,000
| – | – | 0.36% | 47 |
|
2021
Q3 | $1.66M | Buy |
+28,000
| New | +$1.66M | 0.4% | 44 |
|